{"id":74292,"date":"2017-12-08T08:42:49","date_gmt":"2017-12-08T16:42:49","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2017\/12\/boosting-mitochondrial-quality-control-to-combat-alzheimers"},"modified":"2017-12-17T00:01:46","modified_gmt":"2017-12-17T08:01:46","slug":"boosting-mitochondrial-quality-control-to-combat-alzheimers","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2017\/12\/boosting-mitochondrial-quality-control-to-combat-alzheimers","title":{"rendered":"Boosting Mitochondrial Quality Control to Combat Alzheimers"},"content":{"rendered":"<p><a class=\"aligncenter blog-photo\" href=\"https:\/\/lifeboat.com\/blog.images\/boosting-mitochondrial-quality-control-to-combat-alzheimers.jpg\"><\/a><\/p>\n<p>Scientists at the \u00c9cole polytechnique f\u00e9d\u00e9rale de Lausanne (EPFL) have found a way to make mitochondria more resistant to damage, which could potentially be used to halt Alzheimer\u2019s and other, similar, diseases.<\/p>\n<p>Globally, Alzheimer\u2019s disease is the most common form of dementia and cause of neurodegeneration. It causes brain damage and symptoms such as long-term memory loss. It is an amyloid-based disease, with the characteristic hallmark being the formation of toxic plaques in the brain made from the aggregated beta-amyloid inside the neurons.<\/p>\n<p><!-- Link: <a href=\"https:\/\/www.leafscience.org\/boosting-mitochondrial-quality-control-to-combat-alzheimers\/\">https:\/\/www.leafscience.org\/boosting-mitochondrial-quality-c...lzheimers\/<\/a> --><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Scientists at the \u00c9cole polytechnique f\u00e9d\u00e9rale de Lausanne (EPFL) have found a way to make mitochondria more resistant to damage, which could potentially be used to halt Alzheimer\u2019s and other, similar, diseases. Globally, Alzheimer\u2019s disease is the most common form of dementia and cause of neurodegeneration. It causes brain damage and symptoms such as long-term [\u2026]<\/p>\n","protected":false},"author":370,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11,47],"tags":[],"class_list":["post-74292","post","type-post","status-publish","format-standard","hentry","category-biotech-medical","category-neuroscience"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/74292","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/370"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=74292"}],"version-history":[{"count":1,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/74292\/revisions"}],"predecessor-version":[{"id":74364,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/74292\/revisions\/74364"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=74292"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=74292"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=74292"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}